Yousif F B, Bolger G T, Ruzycky A, Triggle D J
Can J Physiol Pharmacol. 1985 May;63(5):453-62. doi: 10.1139/y85-079.
The actions of a series of 15 Ca2+ channel antagonists including D-600, nifedipine, and diltiazem were examined against K+ depolarization and muscarinic receptor induced responses in guinea pig bladder smooth muscle. Responses of bladder are very dependent upon extracellular Ca2+ and sensitive to the Ca2+ channel antagonists, the tonic component more than the phasic component of response. Regardless of stimulant, K+ or methylfurmethide (MF), or component of response, the same rank order of antagonist activities is expressed, suggestive of a single structure-activity relationship and the existence of a single category of binding site which may, however, exist in several affinity states. High affinity binding of [3H]nitrendipine (KD = 1.1 X 10(-10) M) occurs in bladder membranes, and similar high affinity binding was found in microsomal preparations from other smooth muscles including guinea pig and rat lung, rat vas deferens, uterus, and stomach. [3H]nitrendipine binding in the bladder was sensitive to displacement by other 1,4-dihydropyridines, paralleling their pharmacologic activities and showing excellent agreement with binding data previously obtained for guinea pig ileal smooth muscle. Comparison of pharmacologic data for inhibition of K+- and MF-induced responses by a common series of Ca2+ channel antagonists in bladder and ileum revealed excellent correlations. Neither pharmacologic nor binding studies suggest significant differences in Ca2+ channel antagonist properties in smooth muscle from bladder and intestine.
研究了包括D - 600、硝苯地平和地尔硫䓬在内的一系列15种钙通道拮抗剂对豚鼠膀胱平滑肌中钾离子去极化和毒蕈碱受体诱导反应的作用。膀胱的反应非常依赖细胞外钙离子,并且对钙通道拮抗剂敏感,反应的紧张性成分比时相性成分更敏感。无论刺激物是钾离子还是甲基呋硫翁(MF),也无论反应成分如何,拮抗剂活性都表现出相同的排序,这表明存在单一的构效关系以及单一类别的结合位点,然而该结合位点可能存在几种亲和力状态。[3H]尼群地平(KD = 1.1×10⁻¹⁰ M)在膀胱膜中发生高亲和力结合,并且在包括豚鼠和大鼠肺、大鼠输精管、子宫和胃在内的其他平滑肌的微粒体制剂中也发现了类似的高亲和力结合。膀胱中的[3H]尼群地平结合对其他1,4 - 二氢吡啶的置换敏感,这与它们的药理活性平行,并且与先前在豚鼠回肠平滑肌中获得的结合数据显示出极好的一致性。比较一系列常见钙通道拮抗剂对膀胱和回肠中钾离子和MF诱导反应的抑制的药理数据,发现具有极好的相关性。药理研究和结合研究均未表明膀胱和平滑肌中钙通道拮抗剂特性存在显著差异。